Az egyetem munkatársai által beadott védőoltások száma - 2023. január 22.
545262 Összes oltás

1: Nagy Á, Munkácsy G, Győrffy B. Pancancer survival analysis of cancer hallmark
genes. Sci Rep. 2021 Mar 15;11(1):6047. doi: 10.1038/s41598-021-84787-5. PMID:
33723286; PMCID: PMC7961001.

2: Breitenecker K, Homolya M, Luca AC, Lang V, Trenk C, Petroczi G, Mohrherr J,
Horvath J, Moritsch S, Haas L, Kurnaeva M, Eferl R, Stoiber D, Moriggl R, Bilban
M, Obenauf AC, Ferran C, Dome B, Laszlo V, Győrffy B, Dezso K, Moldvay J,
Casanova E, Moll HP. Down-regulation of A20 promotes immune escape of lung
adenocarcinomas. Sci Transl Med. 2021 Jul 7;13(601):eabc3911. doi:
10.1126/scitranslmed.abc3911. PMID: 34233950; PMCID: PMC7611502.

3: Lánczky A, Győrffy B. Web-Based Survival Analysis Tool Tailored for Medical
Research (KMplot): Development and Implementation. J Med Internet Res. 2021 Jul
26;23(7):e27633. doi: 10.2196/27633. PMID: 34309564; PMCID: PMC8367126.

4: Andrijes R, Hejmadi RK, Pugh M, Rajesh S, Novitskaya V, Ibrahim M, Overduin
M, Tselepis C, Middleton GW, Győrffy B, Beggs AD, Berditchevski F. Tetraspanin 6
is a regulator of carcinogenesis in colorectal cancer. Proc Natl Acad Sci U S A.
2021 Sep 28;118(39):e2011411118. doi: 10.1073/pnas.2011411118. PMID: 34521767;
PMCID: PMC8488650.

5: Beatson RE, Parente-Pereira AC, Halim L, Cozzetto D, Hull C, Whilding LM,
Martinez O, Taylor CA, Obajdin J, Luu Hoang KN, Draper B, Iqbal A, Hardiman T,
Zabinski T, Man F, de Rosales RTM, Xie J, Aswad F, Achkova D, Joseph CR, Ciprut
S, Adami A, Roider HG, Hess-Stumpp H, Győrffy B, Quist J, Grigoriadis A, Sommer
A, Tutt ANJ, Davies DM, Maher J. TGF-β1 potentiates Vγ9Vδ2 T cell adoptive
immunotherapy of cancer. Cell Rep Med. 2021 Dec 21;2(12):100473. doi:
10.1016/j.xcrm.2021.100473. PMID: 35028614; PMCID: PMC8714942.

6: Prekovic S, Schuurman K, Mayayo-Peralta I, Manjón AG, Buijs M, Yavuz S,
Wellenstein MD, Barrera A, Monkhorst K, Huber A, Morris B, Lieftink C,
Chalkiadakis T, Alkan F, Silva J, Győrffy B, Hoekman L, van den Broek B,
Teunissen H, Debets DO, Severson T, Jonkers J, Reddy T, de Visser KE, Faller W,
Beijersbergen R, Altelaar M, de Wit E, Medema R, Zwart W. Glucocorticoid
receptor triggers a reversible drug-tolerant dormancy state with acquired
therapeutic vulnerabilities in lung cancer. Nat Commun. 2021 Jul 16;12(1):4360.
doi: 10.1038/s41467-021-24537-3. PMID: 34272384; PMCID: PMC8285479.

7: Menyhárt O, Győrffy B. Multi-omics approaches in cancer research with
applications in tumor subtyping, prognosis, and diagnosis. Comput Struct
Biotechnol J. 2021 Jan 22;19:949-960. doi: 10.1016/j.csbj.2021.01.009. PMID:
33613862; PMCID: PMC7868685.

8: Garcia-Garcia S, Rodrigo-Faus M, Fonseca N, Manzano S, Győrffy B, Ocaña A,
Bragado P, Porras A, Gutierrez-Uzquiza A. HGK promotes metastatic dissemination
in prostate cancer. Sci Rep. 2021 Jun 10;11(1):12287. doi:
10.1038/s41598-021-91292-2. PMID: 34112843; PMCID: PMC8192525.

9: Milosevits G, Mészáros T, Őrfi E, Bakos T, Garami M, Kovács G, Dézsi L, Hamar
P, Győrffy B, Szabó A, Szénási G, Szebeni J. Complement-mediated
hypersensitivity reactions to an amphotericin B-containing lipid complex
(Abelcet) in pediatric patients and anesthetized rats: Benefits of slow
infusion. Nanomedicine. 2021 Jun;34:102366. doi: 10.1016/j.nano.2021.102366.
Epub 2021 Feb 5. PMID: 33549818.

10: Aslan M, Hsu EC, Garcia-Marques FJ, Bermudez A, Liu S, Shen M, West M, Zhang
CA, Rice MA, Brooks JD, West R, Pitteri SJ, Győrffy B, Stoyanova T. Oncogene-
mediated metabolic gene signature predicts breast cancer outcome. NPJ Breast
Cancer. 2021 Oct 28;7(1):141. doi: 10.1038/s41523-021-00341-6. PMID: 34711841;
PMCID: PMC8553750.

11: Menyhárt O, Fekete JT, Győrffy B. Gene expression-based biomarkers
designating glioblastomas resistant to multiple treatment strategies.
Carcinogenesis. 2021 Jun 21;42(6):804-813. doi: 10.1093/carcin/bgab024. PMID:
33754151; PMCID: PMC8215594.

12: Nagy Á, Pongor S, Győrffy B. Different mutations in SARS-CoV-2 associate
with severe and mild outcome. Int J Antimicrob Agents. 2021 Feb;57(2):106272.
doi: 10.1016/j.ijantimicag.2020.106272. Epub 2020 Dec 23. PMID: 33347989; PMCID:
PMC7755579.

13: Alcaraz-Sanabria A, Cabañas Morafraile E, Fernández-Hinojal G, Velasco G,
Pérez-Segura P, Pandiella A, Győrffy B, Ocaña A. Transcriptomic Mapping of Non-
Small Cell Lung Cancer <i>K-RAS</i> p.G12C Mutated Tumors: Identification of
Surfaceome Targets and Immunologic Correlates. Front Immunol. 2022 Feb
1;12:786069. doi: 10.3389/fimmu.2021.786069. PMID: 35178045; PMCID: PMC8843839.

14: Regan JL, Schumacher D, Staudte S, Steffen A, Lesche R, Toedling J, Jourdan
T, Haybaeck J, Mumberg D, Henderson D, Győrffy B, Regenbrecht CRA, Keilholz U,
Schäfer R, Lange M. RNA sequencing of long-term label-retaining colon cancer
stem cells identifies novel regulators of quiescence. iScience. 2021 May
24;24(6):102618. doi: 10.1016/j.isci.2021.102618. PMID: 34142064; PMCID:
PMC8185225.

15: Periyasamy M, Singh AK, Gemma C, Farzan R, Allsopp RC, Shaw JA, Charmsaz S,
Young LS, Cunnea P, Coombes RC, Győrffy B, Buluwela L, Ali S. Induction of
APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed
activation of NF-κB. Oncogene. 2021 Feb;40(6):1077-1090. doi:
10.1038/s41388-020-01583-7. Epub 2020 Dec 15. PMID: 33323971; PMCID: PMC7116738.

16: Erokhin M, Chetverina O, Győrffy B, Tatarskiy VV, Mogila V, Shtil AA,
Roninson IB, Moreaux J, Georgiev P, Cavalli G, Chetverina D. Clinical
Correlations of Polycomb Repressive Complex 2 in Different Tumor Types. Cancers
(Basel). 2021 Jun 24;13(13):3155. doi: 10.3390/cancers13133155. PMID: 34202528;
PMCID: PMC8267669.

17: Menyhart O, Weltz B, Győrffy B. MultipleTesting.com: A tool for life science
researchers for multiple hypothesis testing correction. PLoS One. 2021 Jun
9;16(6):e0245824. doi: 10.1371/journal.pone.0245824. Erratum in: PLoS One. 2022
Sep 9;17(9):e0274662. PMID: 34106935; PMCID: PMC8189492.

18: Ősz Á, Lánczky A, Győrffy B. Survival analysis in breast cancer using
proteomic data from four independent datasets. Sci Rep. 2021 Aug 18;11(1):16787.
doi: 10.1038/s41598-021-96340-5. PMID: 34408238; PMCID: PMC8373859.

19: Gleizes A, Triki M, Bonnet S, Baccari N, Jimenez-Dominguez G, Covinhes A,
Pirot N, Blache P, Yuan R, Győrffy B, Cavaillès V, Lapierre M. RIP140 Represses
Intestinal Paneth Cell Differentiation and Interplays with SOX9 Signaling in
Colorectal Cancer. Cancers (Basel). 2021 Jun 26;13(13):3192. doi:
10.3390/cancers13133192. PMID: 34206767; PMCID: PMC8268705.

20: Kuehn J, Espinoza-Sanchez NA, Teixeira FCOB, Pavão MSG, Kiesel L, Győrffy B,
Greve B, Götte M. Prognostic significance of hedgehog signaling network-related
gene expression in breast cancer patients. J Cell Biochem. 2021
May;122(5):577-597. doi: 10.1002/jcb.29886. Epub 2021 Jan 8. PMID: 33417295.

21: Saiz-Ladera C, Baliu-Piqué M, Cimas FJ, Manzano A, García-Barberán V,
Camarero SC, Hinojal GF, Pandiella A, Győrffy B, Stewart D, Cruz-Hernández JJ,
Pérez-Segura P, Ocana A. Transcriptomic Correlates of Immunologic Activation in
Head and Neck and Cervical Cancer. Front Oncol. 2021 Oct 6;11:714550. doi:
10.3389/fonc.2021.714550. PMID: 34692491; PMCID: PMC8527851.

22: Shafran JS, Jafari N, Casey AN, Győrffy B, Denis GV. BRD4 regulates key
transcription factors that drive epithelial-mesenchymal transition in
castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2021
Mar;24(1):268-277. doi: 10.1038/s41391-020-0246-y. Epub 2020 Jul 21. PMID:
32690869; PMCID: PMC7855805.

23: Noblejas-López MDM, Baliu-Piqué M, Nieto-Jiménez C, Cimas FJ, Morafraile EC,
Pandiella A, Corbi ÁL, Győrffy B, Ocaña A. Transcriptomic Profiles of CD47 in
Breast Tumors Predict Outcome and Are Associated with Immune Activation. Int J
Mol Sci. 2021 Apr 7;22(8):3836. doi: 10.3390/ijms22083836. PMID: 33917174;
PMCID: PMC8067872.

24: Nagy Á, Győrffy B. muTarget: A platform linking gene expression changes and
mutation status in solid tumors. Int J Cancer. 2021 Jan 15;148(2):502-511. doi:
10.1002/ijc.33283. Epub 2020 Sep 17. PMID: 32875562.

25: Bellanger A, Le DT, Vendrell J, Wierinckx A, Pongor LS, Solassol J, Lachuer
J, Clezardin P, Győrffy B, Cohen PA. Exploring the Significance of the Exon
4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer. Front Oncol. 2021
Jul 2;11:647269. doi: 10.3389/fonc.2021.647269. PMID: 34277402; PMCID:
PMC8283766.

26: Listik E, Horst B, Choi AS, Lee NY, Győrffy B, Mythreye K. A bioinformatic
analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic
value in multiple solid tumors. PLoS One. 2021 Apr 5;16(4):e0249558. doi:
10.1371/journal.pone.0249558. PMID: 33819300; PMCID: PMC8021191.

27: Lehotzky A, Oláh J, Fekete JT, Szénási T, Szabó E, Győrffy B, Várady G,
Ovádi J. Co-Transmission of Alpha-Synuclein and TPPP/p25 Inhibits Their
Proteolytic Degradation in Human Cell Models. Front Mol Biosci. 2021 May
18;8:666026. doi: 10.3389/fmolb.2021.666026. PMID: 34084775; PMCID: PMC8167055.

28: Díaz-Gil L, Brasó-Maristany F, Locatelli C, Centa A, Győrffy B, Ocaña A,
Prat A, Pandiella A. Modelling hypersensitivity to trastuzumab defines
biomarkers of response in HER2 positive breast cancer. J Exp Clin Cancer Res.
2021 Oct 7;40(1):313. doi: 10.1186/s13046-021-02098-z. PMID: 34620206; PMCID:
PMC8496101.

29: Panza S, Malivindi R, Caruso A, Russo U, Giordano F, Győrffy B, Gelsomino L,
De Amicis F, Barone I, Conforti FL, Giordano C, Bonofiglio D, Catalano S, Andò
S. Novel Insights into the Antagonistic Effects of Losartan against Angiotensin
II/AGTR1 Signaling in Glioblastoma Cells. Cancers (Basel). 2021 Sep
10;13(18):4555. doi: 10.3390/cancers13184555. PMID: 34572782; PMCID: PMC8469998.

30: Bartha Á, Győrffy B. TNMplot.com: A Web Tool for the Comparison of Gene
Expression in Normal, Tumor and Metastatic Tissues. Int J Mol Sci. 2021 Mar
5;22(5):2622. doi: 10.3390/ijms22052622. PMID: 33807717; PMCID: PMC7961455.

31: Fuentes-Antrás J, Alcaraz-Sanabria AL, Morafraile EC, Noblejas-López MDM,
Galán-Moya EM, Baliu-Pique M, López-Cade I, García-Barberán V, Pérez-Segura P,
Manzano A, Pandiella A, Győrffy B, Ocaña A. Mapping of Genomic Vulnerabilities
in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery
in Breast Cancer. Cancers (Basel). 2021 Feb 17;13(4):833. doi:
10.3390/cancers13040833. PMID: 33671201; PMCID: PMC7922122.

32: Noblejas-López MDM, López-Cade I, Fuentes-Antrás J, Fernández-Hinojal G,
Esteban-Sánchez A, Manzano A, García-Sáenz JÁ, Pérez-Segura P, La Hoya M,
Pandiella A, Győrffy B, García-Barberán V, Ocaña A. Genomic Mapping of Splicing-
Related Genes Identify Amplifications in <i>LSM1</i>, <i>CLNS1A,</i> and
<i>ILF2</i> in Luminal Breast Cancer. Cancers (Basel). 2021 Aug 16;13(16):4118.
doi: 10.3390/cancers13164118. PMID: 34439272; PMCID: PMC8391113.

33: Győrffy B. Survival analysis across the entire transcriptome identifies
biomarkers with the highest prognostic power in breast cancer. Comput Struct
Biotechnol J. 2021 Jul 18;19:4101-4109. doi: 10.1016/j.csbj.2021.07.014. PMID:
34527184; PMCID: PMC8339292.

34: Siddharth S, Parida S, Muniraj N, Hercules S, Lim D, Nagalingam A, Wang C,
Gyorffy B, Daniel JM, Sharma D. Concomitant activation of GLI1 and Notch1
contributes to racial disparity of human triple negative breast cancer
progression. Elife. 2021 Dec 10;10:e70729. doi: 10.7554/eLife.70729. PMID:
34889737; PMCID: PMC8664295.

35: Hargadon KM, Győrffy B, Strong EW. The prognostic significance of FOXC2 gene
expression in cancer: A comprehensive analysis of RNA-seq data from the cancer
genome atlas. Cancer Genet. 2021 Jun;254-255:58-64. doi:
10.1016/j.cancergen.2021.02.005. Epub 2021 Feb 13. PMID: 33636524.

36: Rojas K, Baliu-Piqué M, Manzano A, Saiz-Ladera C, García-Barberán V, Cimas
FJ, Pérez-Segura P, Pandiella A, Győrffy B, Ocana A. In silico transcriptomic
mapping of integrins and immune activation in Basal-like and HER2+ breast
cancer. Cell Oncol (Dordr). 2021 Jun;44(3):569-580. doi:
10.1007/s13402-020-00583-9. Epub 2021 Jan 19. PMID: 33469836.

37: Grillo PK, Győrffy B, Götte M. Prognostic impact of the glypican family of
heparan sulfate proteoglycans on the survival of breast cancer patients. J
Cancer Res Clin Oncol. 2021 Jul;147(7):1937-1955. doi:
10.1007/s00432-021-03597-4. Epub 2021 Mar 19. PMID: 33742285; PMCID: PMC8164625.

38: Nagalingam A, Siddharth S, Parida S, Muniraj N, Avtanski D, Kuppusamy P,
Elsey J, Arbiser JL, Győrffy B, Sharma D. Hyperleptinemia in obese state renders
luminal breast cancers refractory to tamoxifen by coordinating a crosstalk
between Med1, miR205 and ErbB. NPJ Breast Cancer. 2021 Aug 13;7(1):105. doi:
10.1038/s41523-021-00314-9. PMID: 34389732; PMCID: PMC8363746.

39: Kozma GT, Mészáros T, Bakos T, Hennies M, Bencze D, Uzonyi B, Győrffy B,
Cedrone E, Dobrovolskaia MA, Józsi M, Szebeni J. Mini-Factor H Modulates
Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC)
Model: Potential Benefits Against Cytokine Storm. Front Immunol. 2021 Apr
28;12:642860. doi: 10.3389/fimmu.2021.642860. PMID: 33995361; PMCID: PMC8113956.

40: Bozsányi S, Varga NN, Farkas K, Bánvölgyi A, Lőrincz K, Lihacova I, Lihachev
A, Plorina EV, Bartha Á, Jobbágy A, Kuroli E, Paragh G, Holló P, Medvecz M, Kiss
N, Wikonkál NM. Multispectral Imaging Algorithm Predicts Breslow Thickness of
Melanoma. J Clin Med. 2021 Dec 30;11(1):189. doi: 10.3390/jcm11010189. PMID:
35011930; PMCID: PMC8745435.